e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
37.52
+0.08 (+0.21%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11,400,468
Open
38.30
Bid (Size)
37.52 (300)
Ask (Size)
37.69 (500)
Prev. Close
37.44
Today's Range
37.42 - 38.42
52wk Range
35.12 - 81.44
Shares Outstanding
N/A
Dividend Yield
3.11%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Global Pantry Reimagined: Unilever and McCormick Seal $65 Billion Merger Deal
April 09, 2026
In a move that has sent shockwaves through the global consumer staples market, Unilever (NYSE:UL) and McCormick & Company (NYSE:MKC) have officially entered into a definitive agreement to merge...
Via
MarketMinute
Topics
Economy
Supply Chain
The "Daily Pill" Revolution: Eli Lilly’s Orforglipron Shatters Records with 25% Weight Loss
April 08, 2026
In a watershed moment for the pharmaceutical industry, Eli Lilly and Company (NYSE: LLY) has officially crossed the threshold into a new era of metabolic medicine. Freshly released data from the...
Via
MarketMinute
Performance
YTD
-28.4%
-28.4%
1 Month
-1.3%
-1.3%
3 Month
-37.3%
-37.3%
6 Month
-34.7%
-34.7%
1 Year
-42.0%
-42.0%
More News
Read More
Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker?
↗
April 08, 2026
Via
The Motley Fool
3 Absurdly Cheap Dividend Stocks to Buy in April 2026
↗
April 08, 2026
Via
The Motley Fool
Topics
Economy
Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
April 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Goldman Sachs Forecasts 12% S&P 500 Surge in 2026: The Five Pillars of a Maturing Bull Market
April 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
April 06, 2026
Via
MarketMinute
Topics
Economy
World Trade
Nuclear, Pharma & Travel Buybacks: Confident or Cautious Signals?
↗
April 06, 2026
Via
MarketBeat
Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight
↗
April 04, 2026
Via
The Motley Fool
Earnings Revision Momentum: Why Analysts Upgraded S&P 500 Growth to 17%
April 03, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Why Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market
↗
April 03, 2026
Via
The Motley Fool
The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets
April 03, 2026
Via
MarketMinute
Topics
Intellectual Property
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
April 02, 2026
Via
MarketMinute
Topics
Economy
The Evolution of The Cigna Group: A Deep Dive into a Health Services Powerhouse (2026)
April 02, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Lawsuit
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
April 02, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Why Eli Lilly Stock Trounced the Market Today
↗
April 01, 2026
Via
The Motley Fool
Eli Lilly’s $47.8 Billion Masterstroke: The Contessa Acquisition and the New Era of Pharmaceutical Dominance
April 01, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Could This New Approval Be a Turning Point For Novo Nordisk?
↗
April 01, 2026
Via
The Motley Fool
Is This Weight Loss Drug Stock a Buy After a New Approval?
↗
March 31, 2026
Via
The Motley Fool
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
March 31, 2026
Via
Finterra
Topics
Economy
Intellectual Property
1 Reason This Biotech Stock Could Triple Before Year-End
↗
March 29, 2026
Via
The Motley Fool
1 Reason Eli Lilly Stock Is Still a Buy
↗
March 28, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Novo Nordisk: A Strong Contender in the Pharmaceutical Arena
↗
March 27, 2026
Via
The Motley Fool
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via
MarketMinute
Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy?
↗
March 27, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 37.52
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 04/10/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.